Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a global commercial-stage biotechnology company committed to unleashing the power of innovative vaccines to save lives and improve health around ...
The WHO says multiple-dose vials will make it easier and less expensive to immunize pregnant women in low-income countries.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive top-line safety and immunogenicity results from substudy B of the ongoing pivotal Phase 3 clinical trial (NCT05842967) MONeT ...
Emmy Award-winning actress, entrepreneur and mom Keke Palmer partners with Sanofi to help educate families about protection against a serious respiratory syncytial virus (RSV) lung infection BEYFORTUS ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A new dual-antibody treatment shows promise against Respiratory Syncytial Virus (RSV), a ...
In most people, the lung-infecting pathogens known as respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) trigger mild cold-like symptoms. But in infants and seniors, these viruses can ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Researchers studied real-world data on the effectiveness ...
Clover Biopharma announces positive phase 2 data for RSV + hMPV ± PIV3 respiratory combination vaccine candidates in older adults: Shanghai Tuesday, September 8, 2026, 18:00 Hrs ...
Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results